Novo Nordisk Shs Sponsored American DepositReceipt Repr 1 Sh -B- $48.31

down -0.10


22/9/2014 04:00 PM  |  NYSE : NVO  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get NVO Trend Analysis - it has underperformed the S&P 500 by 89%

Partner Headlines

  1. Meet 5 Top International Stocks Not Based In China

    IBD
  2. Five Leading International Stocks Near Buy Points

    IBD
  3. Insider Buys at Halozyme Look to Improve Stock Outlook

    GuruFocus
  4. Booming Biotech Market Benefits REIT BioMed Realty

    IBD
  5. Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM

    GuruFocus
  6. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  7. Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide

    IBD
  8. Mylan shares down on Q2 miss

    IBD
  9. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  10. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  11. Jazz, Novo Among Medicals Showing Healthy Action

    IBD
  12. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  13. Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  14. Novo, Other Medicals Display Healthy Action

    IBD
  15. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  16. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  17. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  18. Novo Nordisk lowers outlook

    IBD
  19. Transport, Drug Stocks Act Well Despite Market Woes

    IBD
  20. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  21. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  22. Stocks Rise In Higher Volume; Anika Jumps On Earnings

    IBD
  23. IBD 50: Auto, Other IBD 50 Stocks Forming Bases

    IBD
  24. Alexion, Biogen Among Leading Big-Cap Biotechs

    IBD
  25. Salix Among Stocks Getting Support At 10-Week Line

    IBD
  26. Assessing the New Boss at National Oilwell Varco

    GuruFocus
  27. Baxter Splitting In Effort To 'Unlock Trapped Value'

    IBD
  28. Drug, Airline Stocks Top Shortened Weekly Review

    IBD
  29. Baxter To Split Into Two Companies; Stock Jumps

    IBD
  30. Novo Nordisk Upgraded to 'Buy'

    FoxBusiness
  31. UPDATE: Novo Nordisk Reports Results from First Phase 3 Trial with N8-GP

    Benzinga
  32. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  33. Drugmakers Like Jazz, Shire Key To Europe's Recovery

    IBD
  34. European ETFs Flying Under The Radar

    Benzinga
  35. Pharmacyclics Hits High As Imbruvica Launches Big

    IBD
  36. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  37. Stocks Gain For Day, Week

    IBD
  38. Shire PLC: Time to Panic?

    GuruFocus
  39. AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is

    GuruFocus
  40. Bristol-Myers' Diabetes Sale Sharpens Biopharma Focus

    IBD
  41. AstraZeneca Buys Out Bristol-Myers' Diabetes Business

    IBD
  42. Benzinga's Volume Movers

    Benzinga
  43. Sanofi Continues to Struggle on Its Path to Recovery

    GuruFocus
  44. Lilly Pumps $700M into Insulin Manufacturing

    FoxBusiness
  45. Vertex Drug, Fastest Blockbuster, Quickly Fading

    YCharts
  46. Novo Nordisk Initiates European Share Buyback

    Benzinga
  47. Time To Consider Investing In Scandinavia (EWD, EFNL, NORW, EDEN, GXF)

    Benzinga
  48. Novo Nordisk Is Crying Foul In Liability Suit

    YCharts
  49. Novo Nordisk Pushes Ahead In Challenging Year

    IBD
  50. Benzinga's Top Downgrades

    Benzinga
Trading Center